# 2024 ESC peripheral arterial and aortic diseases guidelines

Guideline · id `cardio:guideline-esc-2024-peripheral-aortic` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

The 2024 guideline of the European Society of Cardiology on peripheral arterial and aortic diseases. The ESC page says it is the first time the society has put recommendations for the two groups of disease in one document, and that it updates and consolidates its earlier guidelines of 2017 and 2014. ESC content is cite only in this atlas, so it states what it read in its own words.

## Technical summary

European Heart Journal 2024;45(36):3538-3700, doi 10.1093/eurheartj/ehae179, PMID 39210722. The ESC page dates the guideline 30 Aug, 2024 and PubMed gives the issue date 2024-09-29. PubMed names the ESC Scientific Document Group as author, holds no abstract, lists no PMC copy and lists no correction. Only the ESC page summary and the PubMed record were read; the recommendations were not.

## Claims, with the population each applies to

## Context: Patients with peripheral arterial and aortic diseases (2024 ESC guideline)

Recipient: Recipient not specified; Population: Patients of any age who have peripheral arterial or aortic diseases, according to the ESC page summary. It gives no inclusion criteria.; Care setting: Not stated on the ESC page.; Geography: Europe (a European Society of Cardiology guideline; the page names no jurisdiction); Life stage: Not stated on the ESC page beyond all ages; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (guideline context)

### The ESC page for this guideline, dated 30 August 2024, says it is the first time the society has put recommendations for the two groups of disease in one document, and that it updates and consolidates its 2017 guideline on peripheral arterial diseases and its 2014 guideline on aortic diseases. The page says the focus is mainly on atherosclerotic arterial diseases, with non-atherosclerotic genetic conditions also considered, and that the guideline aims to help clinicians manage patients of any age.

- Category: Description
- Evidence stage: Guidance
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients of any age who have peripheral arterial or aortic diseases, according to the ESC page summary. It gives no inclusion criteria.; Care setting: Not stated on the ESC page.; Geography: Europe (a European Society of Cardiology guideline; the page names no jurisdiction); Life stage: Not stated on the ESC page beyond all ages; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (guideline context)
- Limitations: Only the ESC page summary and the PubMed record (which holds no abstract) were read; the guideline text, its recommendations and their classes were not. ESC content is cite only, so this atlas states the summary in its own words.
- Last checked: 2026-10-30
- Sources:
  1. Supports: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Guideline, edition Issued by the European Society of Cardiology and published in European Heart Journal 45(36):3538-3700 (PubMed issue date 2024-09-29; the ESC page dates the guideline 30 Aug, 2024). PubMed holds no abstract and lists no PMC copy; the guideline text was not read. A search of PubMed on 2026-10-30 for the title returned this record (PMID 39210722) and Crossref returned the same DOI. The publisher field is the journal title as PubMed gives it.) <https://doi.org/10.1093/eurheartj/ehae179>
     Locator: Summary paragraph 1, sentence 1, fragments 1 to 3. Retrieved 2026-10-30T19:46:55Z. Source state: Current. Version fingerprint: 423fa558a9fb31636d43e7f343a55f3b3e8a49273cf7971c7cb36f3427c62b34.
     How it applies: The first merged guideline for the two groups of disease; replaces the 2017 and 2014 guidelines.
  2. Supports: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Guideline, edition Issued by the European Society of Cardiology and published in European Heart Journal 45(36):3538-3700 (PubMed issue date 2024-09-29; the ESC page dates the guideline 30 Aug, 2024). PubMed holds no abstract and lists no PMC copy; the guideline text was not read. A search of PubMed on 2026-10-30 for the title returned this record (PMID 39210722) and Crossref returned the same DOI. The publisher field is the journal title as PubMed gives it.) <https://doi.org/10.1093/eurheartj/ehae179>
     Locator: Summary paragraph 1, sentence 2. Retrieved 2026-10-30T19:46:55Z. Source state: Current. Version fingerprint: 423fa558a9fb31636d43e7f343a55f3b3e8a49273cf7971c7cb36f3427c62b34.
     How it applies: Focus on atherosclerotic arterial diseases.
  3. Supports: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Guideline, edition Issued by the European Society of Cardiology and published in European Heart Journal 45(36):3538-3700 (PubMed issue date 2024-09-29; the ESC page dates the guideline 30 Aug, 2024). PubMed holds no abstract and lists no PMC copy; the guideline text was not read. A search of PubMed on 2026-10-30 for the title returned this record (PMID 39210722) and Crossref returned the same DOI. The publisher field is the journal title as PubMed gives it.) <https://doi.org/10.1093/eurheartj/ehae179>
     Locator: Summary paragraph 2, last sentence (last clause). Retrieved 2026-10-30T19:46:55Z. Source state: Current. Version fingerprint: 423fa558a9fb31636d43e7f343a55f3b3e8a49273cf7971c7cb36f3427c62b34.
     How it applies: Meant for patients of all ages.
  4. Supports: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Guideline, edition Issued by the European Society of Cardiology and published in European Heart Journal 45(36):3538-3700 (PubMed issue date 2024-09-29; the ESC page dates the guideline 30 Aug, 2024). PubMed holds no abstract and lists no PMC copy; the guideline text was not read. A search of PubMed on 2026-10-30 for the title returned this record (PMID 39210722) and Crossref returned the same DOI. The publisher field is the journal title as PubMed gives it.) <https://doi.org/10.1093/eurheartj/ehae179>
     Locator: Page date line. Retrieved 2026-10-30T19:46:55Z. Source state: Current. Version fingerprint: 423fa558a9fb31636d43e7f343a55f3b3e8a49273cf7971c7cb36f3427c62b34.
     How it applies: The page date.

## Provenance

Content hash: b5615380b86c0c02b7bc74e3c3bf90aad1e46885df7539c8b811ff3dd9d1760b
Last substantive edit: 2026-10-30
Evidence last checked: 2026-10-30
